Dr Gottlieb trained at Brown University, University of Chicago and Mt Sinai in New York. He has been at the University of Maryland since 1988, and is currently Professor of Medicine, and Director of the Clinical Research Program in Cardiology
Dr. Gottlieb’s investigations center on the physiology and therapy of congestive heart failure. This has included a particular interest in neurohormonal activation and renal function in CHF patients. He is particularly interested in the interaction of heart failure and renal dysfunction, having studied the impact of adenosine antagonists and other medications and interventions on renal function and the physiology of renal function in heart failure patients. He investigates new therapies, now working on new inotropes, vasodilators, and devices. He was United States Principal Investigator of the ground-breaking MERIT-HF evaluation of beta blockers. He has published about the interaction of depression and heart failure, and he has investigated the effects of home telemonitoring, sleep abnormalities and genetic polymorphisms in heart failure patients.
Dr. Gottlieb's special interests include cardia amyloidosis, cardio renal syndrome, congestive heart failure, as well as research trials in heart failure.
